David Thomson
2012 - MannKind
In 2012, David Thomson earned a total compensation of $1.1M as Corporate Vice President, General Counsel and Secretary at MannKind, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $111,282 |
|---|---|
| Option Awards | $531,348 |
| Salary | $371,508 |
| Stock Awards | $40,600 |
| Other | $29,313 |
| Total | $1,084,051 |
Thomson received $531.3K in option awards, accounting for 49% of the total pay in 2012.
Thomson also received $111.3K in non-equity incentive plan, $371.5K in salary, $40.6K in stock awards and $29.3K in other compensation.
Rankings
In 2012, David Thomson's compensation ranked 5,799th out of 11,487 executives tracked by ExecPay. In other words, Thomson earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,799 out of 11,487 | 50th |
Division Manufacturing | 2,059 out of 4,253 | 52nd |
Major group Chemicals And Allied Products | 511 out of 1,198 | 57th |
Industry group Drugs | 346 out of 920 | 62nd |
Industry Pharmaceutical Preparations | 272 out of 700 | 61st |
Source: SEC filing on April 10, 2015.
Thomson's colleagues
We found four more compensation records of executives who worked with David Thomson at MannKind in 2012.
News
PRECISION BIOSCIENCES CEO Matthew Kane's 2020 pay slips 15% to $1.8M
April 12, 2021
MannKind CEO Michael PharmD's 2019 pay rises 3% to $1.6M
April 10, 2020
PRECISION BIOSCIENCES Chief Medical Officer Christopher Heery receives $2.2M in 2019
March 27, 2020
MannKind CEO Michael Castagna's 2018 pay rises 13% to $1.5M
March 28, 2019